Dentists in Gonzales, LA Accepting Medicare

30 Dentists found. Showing 21 - 30

Scott Clayton Kogler Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 306 S Burnside Ave, Gonzales, LA 70737 Phone: 225-621-2703    Fax: 225-644-0493

Garrett Lipsey Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 40470 Germany Rd, Gonzales, LA 70737 Phone: 225-622-2022

Dr. Krishna Anil Kumar, DDS Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 40470 Germany Rd, Gonzales, LA 70737 Phone: 225-622-2022

Dr. Daniel Hilaire Gonzales, DDS Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 40470 Germany Rd, Gonzales, LA 70737 Phone: 225-622-2022

Byron R Rome, DDS, APDC Dentist Medicare: Not Enrolled in Medicare Practice Location: 306 S Burnside Ave, Gonzales, LA 70737 Phone: 225-621-2700    Fax: 225-644-0493

Dr. Camille Joseph Russo Iii, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1504 E Highway 30, Gonzales, LA 70737 Phone: 225-644-5311    Fax: 225-644-5312

Kacie Teague, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 13317 Highway 44, Gonzales, LA 70737 Phone: 225-644-4000

Dr. Bradley James Killebrew, DDS Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 1116 S Purpera Ave, Gonzales, LA 70737 Phone: 225-647-3577

Dr. Frances E Rensch, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 14639 Airline Hwy Ste 111112, Gonzales, LA 70737 Phone: 225-402-4118

Dr. Celeste Edwards, DDS Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 119 S Airline Hwy, Gonzales, LA 70737 Phone: 225-308-3435

News Archive

Using genome-wide CRISPR technology to identify leukemia's weakness

A team of researchers at University of California San Diego School of Medicine and Moores Cancer Center used CRISPR technology to identify key regulators of aggressive chronic myeloid leukemia, a type of cancer that remains difficult to treat and is marked by frequent relapse.

Phase 3 study: Tapentadol ER lowers incidence of gastrointestinal adverse events

A Phase 3 open-label study, recently published online by Pain Practice, has compared tapentadol extended release tablets, an investigational pain medication, to an existing prescription pain medication, oxycodone controlled release tablets.

Health care lobbyists spend big to win big, consumer groups fight industry deals

Health care lobbyists are on track to set new spending records this year, with some individual companies nearly doubling their investment compared to previous periods, USA Today reports. The Pharmaceutical Research and Manufacturers of America spent almost as much by September as it did in the entire year in 2008. America's Health Insurance Plans has spent $1 million more so far this year than over the same period last year (Schouten, 10/21).

Enrollment begins in Phase 2 trial of RegeneRx's RGN-259 in dry eye associated with graft vs. host disease

RegeneRx Biopharmaceuticals, Inc. announced today that the first patient has been screened and is being enrolled in a Phase 2 clinical trial testing the Company's drug candidate RGN-259 in patients with dry eye associated with graft vs. host disease. The double-blind, placebo-controlled, investigator-sponsored trial is expected to enroll a total of 20 patients over the next several months, with data reported later in 2011. RGN-259 is a sterile, preservative-free topical eye drop formulation of the novel therapeutic peptide Thymosin beta 4, or Tβ4.

Read more Medical News

› Verified 5 days ago

• 1
• 2(current)